Chemotherapy remains essential for aggressive blood cancers, while targeted therapy offers a personalised approach for chronic conditions with fewer side effects. For cancers like CLL, targeted therapies have revolutionised treatment by focusing on specific cancer cell pathways. The choice between treatments depends on the cancer type, stage, and the patient’s medical profile.